{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:01:51Z","timestamp":1775948511709,"version":"3.50.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly","doi-asserted-by":"publisher","award":["NCT03057951"],"award-info":[{"award-number":["NCT03057951"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"DOI":"10.1093\/eurheartj\/ehae864","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:54:44Z","timestamp":1733867684000},"page":"1074-1077","source":"Crossref","is-referenced-by-count":5,"title":["Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[{"name":"UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, Porto 4200-319 ,","place":["Portugal"]},{"name":"Heart Failure Clinic, Internal Medicine Department, Centro Hospitalar de Vila Nova de Gaia , Espinho ,","place":["Portugal"]},{"name":"Universit\u00e9 de Lorraine, INSERM, Centre d'Investigations Cliniques Plurith\u00e9matique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, INSERM, Centre d'Investigations Cliniques Plurith\u00e9matique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[{"name":"UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, Porto 4200-319 ,","place":["Portugal"]},{"name":"Internal Medicine Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[{"name":"UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, Porto 4200-319 ,","place":["Portugal"]},{"name":"Endocrinology Department, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens School of Medicine , Athens ,","place":["Greece"]}]},{"given":"Stuart J","family":"Pocock","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine , London ,","place":["UK"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-4720","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Research Institute , Dallas, TX ,","place":["USA"]},{"name":"University of Mississippi , Jackson, MS ,","place":["USA"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2387","authenticated-orcid":false,"given":"Milton","family":"Packer","sequence":"additional","affiliation":[{"name":"Baylor Heart and Vascular Institute , Dallas, TX ,","place":["USA"]},{"name":"Imperial College , London ,","place":["UK"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-8683","authenticated-orcid":false,"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]},{"name":"Institute of Heart Diseases, Wroc\u0142aw Medical University , Wroc\u0142aw ,","place":["Poland"]}]}],"member":"286","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2025031314402929600_ehae864-B1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation"},{"key":"2025031314402929600_ehae864-B2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2025031314402929600_ehae864-B3","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ejhf.2992","article-title":"Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors","volume":"25","author":"Marques","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025031314402929600_ehae864-B4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ejhf.2409","article-title":"Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced","volume":"24","author":"Ferreira","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025031314402929600_ehae864-B5","doi-asserted-by":"publisher","first-page":"e010613","DOI":"10.1161\/CIRCHEARTFAILURE.123.010613","article-title":"SGLT2 inhibitor-related polycythemia in a patient with chronic heart failure: a potential severe adverse event","volume":"16","author":"Tukker","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2025031314402929600_ehae864-B6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2025031314402929600_ehae864-B7","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300049","article-title":"Dapagliflozin and anemia in patients with chronic kidney disease","volume":"2","author":"Koshino","year":"2023","journal-title":"NEJM Evid"},{"key":"2025031314402929600_ehae864-B8","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/dom.13295","article-title":"SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"20","author":"Guo","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/11\/1074\/60968390\/ehae864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/11\/1074\/60968390\/ehae864.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T14:42:07Z","timestamp":1741876927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/11\/1074\/7918078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":8,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2025,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae864","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,14]]},"published":{"date-parts":[[2024,12,6]]}}}